Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
Do you have a preference between midodrine and droxidopa for patients with ESKD who experience intradialytic hypotension?
Related Questions
Do you avoid sodium zirconium cyclosilicate use in your patients with ESKD and hyperkalemia who also have peripheral edema?
How do you work up and manage an ESKD patient with controlled blood pressure who complains of recurrent headaches while on hemodialysis?
Are there instances when you would prescribe a phosphate binder to an ESKD patient on hemodialysis who has a phosphorus level in the target range of less than 5.5 mg/dL?
Do you prefer automated peritoneal dialysis during the day or night for a hospitalized patient with ESKD on PD?
Would you recommend pre-dialysis exercise for an ESKD patient as a means of cardioprotection?
What degree of prolactin elevation is typically seen in patients with end stage kidney disease on hemodialysis?
Would you refer an ESKD patient with an identified living donor for AV access placement if kidney transplantation is anticipated in 4 months?
How do you counsel patients on peritoneal dialysis regarding the safety of engaging in aerobic and resistance exercises, considering the risk of developing abdominal wall complications?
Do you use the same hemoglobin target as an ESKD patient for an outpatient with AKI-D who has been receiving dialysis for more than 30 days and is prescribed an ESA?
How long do you recommend waiting before repeating a serum electrolyte panel after the conclusion of an intermittent hemodialysis session to ensure accurate results are obtained?
